Evidence map›Paper›PMID 35358418›Full record

ReviewThe lancet. HIV2022

Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?

Heather-Marie A Schmidt, Robin Schaefer, Van Thi Thuy Nguyen, Mopo Radebe, Omar Sued, Michelle Rodolph, Nathan Ford, Rachel Baggaley

Open access · greenAbstract readReview
In one paragraph

Review in The lancet. HIV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Heather-Marie A SchmidtUNAIDS Regional Office for Asia and the Pacific, Bangkok, Thailand; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Robin SchaeferGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Van Thi Thuy NguyenWorld Health Organization, Hanoi, Vietnam.
Mopo RadebeWorld Health Organization, Pretoria, South Africa.
Omar SuedPan American Health Organization, Washington, DC, USA.
Michelle RodolphGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Nathan FordGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland. Electronic address: fordn@who.int.
Rachel BaggaleyGlobal HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
World Health Organization · CHWorld Health Organization Regional Office for the Americas · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

Task sharing has been one of the most important enabling policies supporting the global expansion of access to HIV testing and treatment. The WHO public health approach, which relies on delivery of antiretroviral therapy (ART) by nurses, has enabled a trebling of the number of people receiving ART during the past decade. WHO recognises that HIV pre-exposure prophylaxis (PrEP) can also be provided by nurses; however, many countries still do not have policies in place that support nurse provision of PrEP. In sub-Saharan Africa, most countries allow nurses to prescribe ART, but only a few countries have policies in place that allow nurses to prescribe PrEP. Nurse-led PrEP delivery is particularly low in the Asia-Pacific region, which has some of the world's fastest growing epidemics. Even in many high-income countries, PrEP scale-up has been limited because policies often require medical doctors or specialists to prescribe. Service providers in many countries are coming to realise that scaling up access to PrEP cannot be achieved by medical doctors alone, and nurse-led PrEP delivery can help to lay the groundwork for supporting uptake of other HIV prevention approaches that will become available in the future. Countries with policies that authorise nurses to prescribe ART could be early adopters and help to pave the way for wider adoption of nurse-led PrEP delivery.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansPublic HealthAnti-HIV Agents

Identifiers

PMID35358418
PMCPMC9046094
OpenAlexW4220881240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.